Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.

Vincent Q-H TrinhChanjuan ShiChangqing Ma

Published in: Histopathology (2020)

Our results show that gastric neuroendocrine tumours of long-term PPI users are probably less aggressive compared to Type III sporadic tumours and have an indolent disease course. Our findings support the classification of gastric neuroendocrine tumours in long-term PPI users as a separate subtype.

Keyphrases

type iii
machine learning
protein protein
late onset
small molecule
early onset
amyotrophic lateral sclerosis